Reference Product

US FDA unveils long-awaited biosimilar guidance

US FDA unveils long-awaited biosimilar guidance

By Zachary Brennan

The FDA has finally released its biosimilar draft guidance for industry, which details how it will evaluate comparative analytical characterization of the biosimilar in relation to the reference product.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers